Inaktiver Wert

Andere Sprachen Tekmira Pharmaceuticals Corporation Toronto S.E.

Aktien

TKM

CA87911B2093

TKM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Whitefort Capital Management Engages with Arbutus Biopharma	09.05.
Arbutus to Participate in Two Upcoming Investor Conferences	07.05.
Arbutus Biopharma : Corporate Presentation - May 2024	02.05.
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M	02.05.
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M, vs. Street Est of $3.7M	02.05.
Arbutus: Q1 Earnings Snapshot	02.05.
Arbutus Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	02.05.
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update	02.05.
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024	02.05.
Arbutus Biopharma Corporation Announces Retirement of Chief Scientific Officer, Michael J. Sofia Effective December 31, 2024	02.05.
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update	18.04.
Arbutus Biopharma : Corporate Presentation - April 2024	15.04.
Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit	05.04.
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna	04.04.
Moderna Suffers Setback in Lawsuit by Arbutus	04.04.
Moderna shares fall after judge sides with Arbutus in patent fight	03.04.
Arbutus to Participate in Two Upcoming Investor Conferences	08.03.
Arbutus to Participate in Two Upcoming Investor Conferences	08.03.
Arbutus Biopharma Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update	01.03.
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Tekmira Pharmaceuticals Corporation Toronto S.E.

Aktien

TKM

CA87911B2093

TKM

Andere Sprachen

Filter